Perilous Reversal Watch: Abiomed (ABMD)

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified Abiomed ( ABMD) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Abiomed as such a stock due to the following factors:

ABMD has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $48.5 million.

ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. ABMD has a PE ratio of 148.0. Currently there are 4 analysts that rate Abiomed a buy, 1 analyst rates it a sell, and 4 rate it a hold.

The average volume for Abiomed has been 500,400 shares per day over the past 30 days. Abiomed has a market cap of $2.7 billion and is part of the health care sector and health services industry. The stock has a beta of 1.36 and a short float of 12.8% with 4.77 days to cover. Shares are up 71.2% year-to-date as of the close of trading on Tuesday.